TY - JOUR
T1 - The Impact of Race on the Prognosis of Preclinical Diastolic Dysfunction
T2 - A Large Multiracial Urban Population Study
AU - Shan, Jian
AU - Zhang, Lili
AU - Holmes, Anthony A.
AU - Taub, Cynthia C.
N1 - Publisher Copyright:
© 2016 Elsevier Inc.
PY - 2016/2/1
Y1 - 2016/2/1
N2 - Background This study was performed to assess the impact of race on the incidence of heart failure and survival in patients with preclinical diastolic dysfunction. Methods All adults during a 5-year period with grade 1 diastolic dysfunction on echocardiogram, left ventricular ejection fraction ≥50%, and no diagnosis of heart failure were included in this study. Clinical endpoints were new diagnosis of heart failure (International Classification of Diseases-Ninth Revision code 428.0) and all-cause mortality. A total of 7878 patients: 20.8% non-Hispanic White, 35.8% non-Hispanic Black, and 31.0% Hispanic individuals (mean age was 68 ± 12 years, 37% men) were included in the study. Non-Hispanic Whites were older, more frequently male, and had a higher mean socioeconomic status and more antecedent myocardial infarction. Results Non-Hispanic Blacks and Hispanics had more hypertension, diabetes, renal disease, and cerebrovascular disease. After a median follow-up time of 6 years, 1356 patients developed heart failure and 2078 patients died. The 10-year cumulative probabilities of heart failure and all-cause mortality were 23.9% and 32.6%, respectively. Time to incident heart failure was similar among the 3 racial groups. However, non-Hispanic Blacks (hazard ratio 0.80, P =.002) and Hispanics (hazard ratio 0.67, P <.001) experienced lower mortality compared with non-Hispanic Whites, which was confirmed on a propensity-scored sensitivity analysis. Conclusions Time to heart failure was similar among the 3 racial groups, however, non-Hispanic Whites experienced worse survival compared with non-Hispanic Blacks and Hispanics, despite their higher burden of risk factors. The reasons for worse survival in the non-Hispanic white population need to be further explored.
AB - Background This study was performed to assess the impact of race on the incidence of heart failure and survival in patients with preclinical diastolic dysfunction. Methods All adults during a 5-year period with grade 1 diastolic dysfunction on echocardiogram, left ventricular ejection fraction ≥50%, and no diagnosis of heart failure were included in this study. Clinical endpoints were new diagnosis of heart failure (International Classification of Diseases-Ninth Revision code 428.0) and all-cause mortality. A total of 7878 patients: 20.8% non-Hispanic White, 35.8% non-Hispanic Black, and 31.0% Hispanic individuals (mean age was 68 ± 12 years, 37% men) were included in the study. Non-Hispanic Whites were older, more frequently male, and had a higher mean socioeconomic status and more antecedent myocardial infarction. Results Non-Hispanic Blacks and Hispanics had more hypertension, diabetes, renal disease, and cerebrovascular disease. After a median follow-up time of 6 years, 1356 patients developed heart failure and 2078 patients died. The 10-year cumulative probabilities of heart failure and all-cause mortality were 23.9% and 32.6%, respectively. Time to incident heart failure was similar among the 3 racial groups. However, non-Hispanic Blacks (hazard ratio 0.80, P =.002) and Hispanics (hazard ratio 0.67, P <.001) experienced lower mortality compared with non-Hispanic Whites, which was confirmed on a propensity-scored sensitivity analysis. Conclusions Time to heart failure was similar among the 3 racial groups, however, non-Hispanic Whites experienced worse survival compared with non-Hispanic Blacks and Hispanics, despite their higher burden of risk factors. The reasons for worse survival in the non-Hispanic white population need to be further explored.
KW - All-cause mortality
KW - Diastolic dysfunction
KW - Heart failure
KW - Race
KW - Sex
UR - http://www.scopus.com/inward/record.url?scp=84973410489&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84973410489&partnerID=8YFLogxK
U2 - 10.1016/j.amjmed.2015.08.036
DO - 10.1016/j.amjmed.2015.08.036
M3 - Article
C2 - 26475254
AN - SCOPUS:84973410489
SN - 0002-9343
VL - 129
SP - 222.e1-222.e10
JO - American Journal of Medicine
JF - American Journal of Medicine
IS - 2
ER -